N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide CAS#: 906421-01-0

N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide

Basic information Safety Supplier Related

Product Name:

Synonyms:

N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide
Glycinamide, N-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-N-methylglycyl-N,N,N2-trimethyl- (9CI)
KD 027
KD027
KD-027
SLX-2101 KD-027

CAS:

906421-01-0

MF:

C25H35N7O6S

MW:

561.65

Mol File:

906421-01-0.mol

Less

InChIKey: LNDPAVOZUUABGL-UHFFFAOYSA-N
SMILES: C(N(C(=O)CN(S(C1=CC=C(OCC)C(C2=NC(=O)C3=C(C)N=C(CCC)N3N2)=C1)(=O)=O)C)C)(=O)CN(C)C

Less

KD-027, also known as SLx-2101, is a PDE5A inhibitor potentially for the treatment of hypertension.

Zhejiang J&C Biological Technology Co.,Limited

TargetMol Chemicals Inc.

Shanghai Longyu Biotechnology Co., Ltd.

TargetMol Chemicals Inc.

Shaanxi Cuikang Pharmaceutical Technology Co., Ltd